[Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
Seven patients with open angle glaucoma were treated using Dorsolamida twice daily together Betablocant treat. Five patients with secondary glaucoma were treated with Dorsolamida three time daily as well three patients with edematous postimplant keratopathy. Intraocular pressure decreased with an average of 3-4 mm Hg and at the patients with corneal edema that decreased.
Gafencu
O
O
Clinica Oftalmologică, Spitalul Militar Bucureşti.
Armegioiu
M
M
Ionita
M
M
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D002908:Chronic Disease; D003131:Combined Modality Therapy; D015715:Corneal Edema / Q000188:drug therapy / Q000503:physiopathology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide